First participant dosed in Jade’s Phase II JUNIPER trial for IgAN

Jade Biosciences has dosed the first participant in its Phase II JUNIPER clinical trial, evaluating JADE101 for IgAN. The post First participant dosed in Jade’s Phase II JUNIPER trial for IgAN appeared first on Hospital Management .